IRIS
ZERBI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.901
EU - Europa 1.478
AS - Asia 819
AF - Africa 238
SA - Sud America 18
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.472
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.839
FI - Finlandia 410
SG - Singapore 408
IE - Irlanda 339
CN - Cina 298
NG - Nigeria 235
FR - Francia 154
DE - Germania 143
IT - Italia 114
NL - Olanda 94
SE - Svezia 91
CA - Canada 61
GB - Regno Unito 56
TR - Turchia 48
BE - Belgio 32
IL - Israele 24
IN - India 13
AU - Australia 10
IR - Iran 9
CH - Svizzera 8
CL - Cile 8
RU - Federazione Russa 8
AR - Argentina 7
UA - Ucraina 7
JP - Giappone 6
RO - Romania 6
HK - Hong Kong 5
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EU - Europa 3
BR - Brasile 2
ES - Italia 2
GH - Ghana 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
CO - Colombia 1
EG - Egitto 1
IQ - Iraq 1
KH - Cambogia 1
MN - Mongolia 1
PA - Panama 1
PH - Filippine 1
Totale 10.472
Salva come PNG Salva come JPEG
Città #
Wilmington 1.612
Chandler 1.510
San Mateo 582
Ann Arbor 482
Helsinki 410
Dublin 339
Leawood 308
Shanghai 292
Boardman 287
Lawrence 275
Princeton 275
Singapore 271
Benin City 235
New York 184
Woodbridge 155
Paris 153
Ashburn 149
Fairfield 132
Amsterdam 92
Toronto 60
Seattle 53
San Diego 50
London 49
Kocaeli 39
Milan 38
Norwalk 36
Brussels 32
Santa Clara 25
Abbiategrasso 24
Monmouth Junction 19
Falkenstein 16
Redmond 14
Redwood City 14
Milwaukee 12
Washington 12
Phoenix 11
Los Angeles 10
Pune 10
Des Moines 9
Malatya 8
Cambridge 7
Hanover 6
Andover 5
Berlin 5
Collecorvino 5
Falls Church 5
Sacramento 5
Buenos Aires 4
Moscow 4
Buffalo 3
Crema 3
Dhaka 3
Jerusalem 3
Lausanne 3
Pisa 3
Riverview 3
Auckland 2
Belgrade 2
Brno 2
Büdelsdorf 2
Chisinau 2
Clearwater 2
Frankfurt am Main 2
Geneva 2
Henderson 2
Kumasi 2
Lissone 2
Munich 2
Newark 2
Oslo 2
Palermo 2
Rome 2
Shenyang 2
Addison 1
Adliswil 1
Atlanta 1
Augusta 1
Beijing 1
Birmingham 1
Bogotá 1
Bologna 1
Braunschweig 1
Bucharest 1
Cairo 1
Central District 1
Chicago 1
Copenhagen 1
Council Bluffs 1
Cupertino 1
Dallas 1
Den Haag 1
Eden Prairie 1
Fukuoka 1
Genoa 1
Gunzenhausen 1
Hamm 1
Heimberg 1
Houston 1
Istanbul 1
Jacksonville 1
Totale 8.412
Salva come PNG Salva come JPEG
Nome #
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 63
The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma 61
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 60
A Bone in the Pancreas 59
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 58
BEYOND PALLIATION: USING EUS-GUIDED CHOLEDOCHODUODENOSTOMY WITH A LUMEN-APPOSING METAL STENT AS A BRIDGE TO SURGERY 57
The evolution of post-operative pancreatic fistula (POPF) classification: A single-center experience 57
Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer 57
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 56
Commentary to paper "Primary versus secondary delayed gastric emptying (DGE) grades B and C of the International Study Group of Pancreatic Surgery after pancreatoduodenectomy: a retrospective analysis on a group of 132 patients". 56
CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer 55
Diagnostic assessment and outcome of acute pancreatitis in Italy: Results of a prospective multicentre study - ProInf-AISP: Progetto informatizzato pancreatite acuta, Associazione Italiana Studio Pancreas, phase II 55
Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. 55
Serum CA 19-9 in the postsurgical follow-up of patients with pancreatic cancer 55
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 55
Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms 55
An uncommon cause of massive intraperitoneal bleeding: leiomyoblastoma of the stomach. 54
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: What should be the surgeon's choice? 54
AN ONCOCYTIC CARCINOMA OF THE PANCREAS WITH PULMONARY AND SUBCUTANEOUS METASTASES 53
Pancreatoduodenectomy with occlusion of the residual stump by Neoprene injection. 53
Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy 53
Prognostic value of the immune-related transcriptome in biliary tract cancers 53
Final results of a prospective trial of a PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma 52
Assessment of Perioperative Body Composition at Bioimpedance Vector Analysis (BIVA) Predicts Morbidity Following Pancreatic Resection for Cancer 52
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile 52
Effect of Surgeon Volume on Outcome Following Pancreaticoduodenectomy in a High-Volume Hospital 52
Value of abdominal sonography and MR imaging at 0.5 T in preoperative detection of pancreatic insulinoma: A comparison with dynamic CT and angiography 52
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma 52
Application of minimally invasive pancreatic surgery: an Italian survey 52
Characterisation of the immune-related transcriptome in resected biliary tract cancers 52
Pancreatic enzyme replacement therapy in post-pancreatectomy patients. 51
Diagnosis and treatment of acute pancreatitis: The position statement of the Italian Association for the study of the pancreas 51
Consequences of Increases in Antibiotic Resistance Pattern on Outcome of Pancreatic Resection for Cancer 51
Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid beta-cell tumors 51
Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy 51
Enhanced Recovery After Pancreatic Surgery Does One Size Really Fit All? A Clinical Score to Predict the Failure of an Enhanced Recovery Protocol After Pancreaticoduodenectomy 51
Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controoled trial 50
Morphohistological Features of Pancreatic Stump Are the Main Determinant of Pancreatic Fistula after Pancreatoduodenectomy 50
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 49
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 49
Management and Outcomes of Pancreatic Resections Performed in High-Volume Referral and Low-Volume Community Hospitals Lead by Surgeons Who Shared the Same Mentor: The Importance of Training 49
RELIABILITY OF PANCREATIC-CANCER STAGING CLASSIFICATIONS 49
A prospective multicentre survey on the treatment of acute pancreatitis in Italy 49
Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers 49
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 48
Diagnosi e terapia degli insulinomi: esperienza in 28 casi 48
A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive technique and variability of perioperative pathways. 48
Ampullary neuroendocrine neoplasms: surgical experience of a rare and challenging entity 48
A cost-benefit analysis of surgical approach to pancreatic cancer 48
Different reconstruction techniques after pancreatoduodenectomy do not affect clinical and patient reported outcomes. 47
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: A dose-finding study 47
INTRAOPERATIVE RADIATION-THERAPY ADJUVANT TO RESECTION IN THE TREATMENT OF PANCREATIC-CANCER 47
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel 47
Pancreatic metastases: An increasing clinical entity. 46
Preparazione del paziente e vie d'accesso 46
The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: Regulation of expression and potential mechanisms of antimalignant activity 45
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 45
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 45
Pylorus-preserving pancreatoduodenectomy 45
[Advances and perspectives in acute pancreatitis]. FT Novita e prospettive nella pancreatite acuta. 45
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 45
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 45
Role of preoperative biliary stents, bile contamination and antibiotic prophylaxis in surgical site infections after pancreaticoduodenectomy 44
Role of C-Reactive Protein Assessment as Early Predictor of Surgical Site Infections Development after Pancreaticoduodenectomy 44
Pylorus-preserving pancreaticoduodenectomy versus conventional whipple operation 44
Evaluation of UICC TNM classification for pancreatic cancer - A study of 228 patients 44
Beyond Palliation: Using EUS-Guided Choledochoduodenostomy with a Lumen-Apposing Metal Stent as a Bridge to Surgery. A Case Series 44
Intrapancreatic accessory spleen mimicking a neuroendocrine tumor: magnetic resonance findings and possible diagnostic role of different nuclear medicine tests 44
Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms 44
ANDROGENS USEFUL FOR DIAGNOSING PANCREATIC-CANCER 44
PANCREATIC MUCINOUS CYSTIC ADENOCARCINOMA METASTASIS TO THE RECTUM 44
BEHAVIOR OF TUMOR-MARKERS CA19.9, CA195, CAM43, CA242, AND TPS IN THE DIAGNOSIS AND FOLLOW-UP OF PANCREATIC-CANCER 44
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours 44
Parenchyma-sparing surgery for pancreatic endocrine tumors. 44
Arterial vs pancreatic phase: which is the best choice in the evaluation of pancreatic endocrine tumourswith multidetector computed tomography (MDCT)? 44
Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report 44
Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort study 44
Fat-absorptiom and gastroenteric pH profile in postsurgical pancreatic insufficiency: Role of the association of H2-receptor antagonists with pancreatic enzymes 43
Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4 43
Surgical treatment of benign and borderline neoplasms of the pancreatic body 43
Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study 43
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS) 43
European evidence-based guidelines on pancreatic cystic neoplasms 43
A Partnership Model Between High- and Low-Volume Hospitals to Improve Results in Hepatobiliary Pancreatic Surgery 43
Diagnosis of malignant change in duodenal villous adenoma. 42
[Personal experience in surgical resection of pancreatic carcinoma]. FT Esperienza personale nella chirurgia resettiva del carcinoma pancreatico. 42
Eus-Elastography With Strain Ratio in the Diagnosis of Solid Pancreatic Lesions: A Single Center Prospective Cohort Study 42
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 42
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. 42
What is the role of pancreas units today? 42
Combination chemotherapy followed by chemoradiation for stage III pancreatic adenocarcinoma (PA) 42
Accuracy of the plasma amino acid-consumption test in detecting pancreatic diseases is due to different methods 42
Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis 42
Immune infiltrating cells in duodenal cancers 42
Color Doppler imaging in the assessment of vascular involvement by pancreatic carcinoma? 41
ERCP in acute pancreatitis: What takes place in routine clinical practice? 41
Preoperative Biliary Stenting and Major Morbidity After Pancreatoduodenectomy: Does Elapsed Time Matter? The FRAGERITA Study Group 41
Occlusion of the pancreatic duct versus pancreaticojejunostomy - A prospective randomized trial 41
Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma 41
THE ROLE OF EUS-FNA IN THE DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMORS 41
Totale 4.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 0 0 0 0 0 14
2020/20212.928 16 41 10 14 7 933 473 220 557 370 7 280
2021/20221.376 75 14 52 334 15 12 45 217 134 112 280 86
2022/20234.071 613 164 383 442 388 346 7 311 753 357 269 38
2023/20242.179 169 210 464 90 37 211 111 197 53 33 185 419
2024/202555 55 0 0 0 0 0 0 0 0 0 0 0
Totale 10.623